Techbio is a area combining knowledge, know-how and biology to boost scientific processes — and AI has the potential to supercharge the biopharmaceutical business additional. On this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the corporate makes use of AI and machine studying to speed up drug discovery and improvement at scale. Tune in to listen to Gibson focus on how AI is reworking the biopharmaceutical business by growing effectivity and decreasing discovery prices.
Time Stamps
0:58: Background on Recursion
6:23: Recursion’s strategy to drug discovery
12:06: Empirical knowledge era and generative AI prediction
17:46: How supercomputing is accelerating drug discovery
22:32: What’s techbio?
29:15: The longer term — utilizing pure language prompts to work with AI methods
31:44: Recursion’s plans for future
You May Additionally Like:|
Caristo Diagnostics has developed an AI-powered resolution for detecting coronary irritation in cardiac CT scans. Dr. Keith Channon, cofounder and chief medical officer of the corporate, discusses how Caristo makes use of AI to enhance therapy plans and threat predictions by offering patient-specific readouts.
Cofounder of Annalise.ai Aengus Tran on Utilizing AI as a Spell Test for Well being Checks – Ep. 207
Clinician-led healthcare AI firm Harrison.ai has constructed annalise.ai. This AI resolution serves as a “spell checker” for radiologists — flagging essential findings to enhance the velocity and accuracy of radiology picture evaluation, decreasing misdiagnoses. Harrison.ai CEO and cofounder Aengus Tran discusses the potential of autonomous AI methods to scale world healthcare capability.
Matice Founder Jessica Whited on Harnessing Regenerative Species for Medical Breakthroughs – Ep. 198
Matice Biosciences is utilizing AI to review the regeneration of tissues in animal species referred to as super-regenerators, corresponding to salamanders and planarians. Jessica Whited, a regenerative biologist at Harvard and cofounder of Matice Biosciences, discusses the corporate’s aim to harness regenerative species and AI to develop new remedies that assist people heal from accidents with out scarring.
Bojan Tunguz, Johnny Israeli on How AI and Crowdsourcing Can Advance Vaccine Distribution – Ep. 195
Synthetic intelligence is teaming up with crowdsourcing to enhance the thermo-stability of mRNA vaccines, making distribution extra accessible worldwide. Bojan Tunguz, a physicist and senior system software program engineer at NVIDIA, and Johnny Israeli, senior supervisor of AI and cloud software program at NVIDIA, focus on the fusion of AI, crowdsourcing and machine studying and its potential in drug discovery.
Subscribe to the AI Podcast
Get the AI Podcast via iTunes, Google Play, Amazon Music, Castbox, DoggCatcher, Overcast, PlayerFM, Pocket Casts, Podbay, PodBean, PodCruncher, PodKicker, Soundcloud, Spotify, Stitcher and TuneIn.
Make the AI Podcast higher: Have a couple of minutes to spare? Fill out this listener survey.